Application Nr Approved Date Route Status External Links
NDA212489 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ongentys Is Indicated As Adjunctive Treatment To Levodopa/carbidopa In Patients With Parkinson’s Disease (Pd) Experiencing “off” Episodes. Ongentys Is A Catechol-O-Methyltransferase (Comt) Inhibitor Indicated As Adjunctive Treatment To Levodopa/carbidopa In Patients With Parkinson’s Disease (Pd) Experiencing “off” Episodes. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Opicapone

Comments